ReposiTrak(TRAK)
Search documents
ReposiTrak(TRAK) - 2020 Q1 - Quarterly Report
2019-11-07 22:01
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended September 30, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from __________ to _________. Commission File Number 001-34941 PARK CITY GROUP, INC. (Exact name of small business issuer as specified in its charter) (State or other juri ...
ReposiTrak(TRAK) - 2019 Q4 - Earnings Call Transcript
2019-09-13 01:05
Park City Group, Inc. (PCYG) Q4 2019 Results Earnings Conference Call September 12, 2019 4:15 PM ET Company Participants Rob Fink - IR, FNK Randy Fields - Chairman and CEO John Merrill - CFO Conference Call Participants Thomas Forte - D. A. Davidson Operator Greetings, welcome to the Park City Group Fiscal Fourth Quarter and Year End 2019 Earnings Conference Call. [Operator Instructions] Please note, this conference is being recorded. I will now turn the conference over to your host, Rob Fink with FNK IR. ...
ReposiTrak(TRAK) - 2019 Q4 - Annual Report
2019-09-12 20:46
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2019 Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. [ ] Yes [X] No or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 001-34941 (Commission file number) PARK CITY GROUP, INC. (Exact n ...
ReposiTrak(TRAK) - 2019 Q3 - Quarterly Report
2019-05-09 21:26
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended March 31, 2019 Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (Sec.232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to s ...
ReposiTrak(TRAK) - 2019 Q2 - Quarterly Report
2019-02-07 21:17
Revenue Performance - Revenue for the three months ended December 31, 2018, was $5,724,706, a 3% decrease from $5,565,237 in the same period of 2017[77] - Revenue for the six months ended December 31, 2018, was $11,507,231, reflecting a 10% increase from $10,436,871 in the same period of 2017[89] - Management anticipates revenue growth in subsequent periods driven by new customer acquisition and cross-selling existing services[78] Expenses - Cost of services and product support decreased by 11% to $1,270,659 for the three months ended December 31, 2018, compared to $1,426,351 in 2017[79] - Cost of services and product support for the six months ended December 31, 2018, increased by 5% to $2,999,185 from $2,844,364 in 2017[90] - Sales and marketing expenses dropped by 30% to $1,139,855 for the three months ended December 31, 2018, down from $1,621,149 in 2017[81] - Sales and marketing expenses for the six months ended December 31, 2018, decreased by 5% to $3,047,879 compared to $3,207,089 in 2017[91] - General and administrative expenses increased by 16% to $1,326,735 for the three months ended December 31, 2018, compared to $1,140,085 in 2017[83] - General and administrative expenses rose by 9% to $2,470,046 for the six months ended December 31, 2018, up from $2,275,855 in 2017[92] Net Other Income - Net other income for the three months ended December 31, 2018, was $49,150, a significant increase from a net expense of $7,696 in 2017, marking a 739% change[86] - Net other income for the six months ended December 31, 2018 was $73,801, a significant increase of 347% compared to a net other expense of $29,887 for the same period in 2017[95] Cash Flow and Liquidity - Cash and cash equivalents increased by 12% to $16,682,282 as of December 31, 2018, up from $14,892,439 as of June 30, 2018, primarily due to higher cash flows from operations[99] - Net cash provided by operating activities rose by 34% to $1,830,582 for the six months ended December 31, 2018, compared to $1,368,613 in the same period of 2017[100] - Cash used in investing activities decreased by 99% to $3,547 for the six months ended December 31, 2018, down from $288,884 in the prior year, due to reduced fixed asset purchases[101] - Cash used in financing activities decreased by 88% to $37,192 for the six months ended December 31, 2018, compared to $315,227 in the same period of 2017, mainly due to lower dividend payments[102] - The company believes its existing cash and short-term investments are sufficient to fund operations for at least the next twelve months[98] Balance Sheet - Current assets increased by 5% to $25,027,283 as of December 31, 2018, compared to $23,733,461 as of June 30, 2018, driven by a rise in cash[104] - Current liabilities rose by 19% to $9,542,741 as of December 31, 2018, up from $7,989,892 as of June 30, 2018, primarily due to increased amounts drawn on the line of credit[105] - Working capital decreased by $259,027 to $15,484,542 as of December 31, 2018, compared to $15,743,569 at June 30, 2018[103] - Total debt as of December 31, 2018, is $4,954,977, with fixed rate debt at $294,977 (6%) and variable rate debt at $4,660,000 (94%) [121] Investment Portfolio - The fair value of cash in the investment portfolio is $16,682,282, with a weighted average interest rate of 2.21% [121] Internal Controls - The Chief Executive Officer and Chief Financial Officer believe that the company's disclosure controls and procedures are effective as of December 31, 2018 [124] - There have been no changes in the company's internal control over financial reporting that materially affected or are likely to materially affect the company's internal control during the reporting period [124]